期刊簡介 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | DRUG RESISTANCE UPDATES LetPub Score 9.2
50 ratings
Rate
Reputation 10.0 Influence 8.5 Speed 9.6 | ||||||||||||||||||||||||||||||||
期刊簡稱 | DRUG RESIST UPDATE | ||||||||||||||||||||||||||||||||
ISSN | 1368-7646 | ||||||||||||||||||||||||||||||||
E-ISSN | 1532-2084 | ||||||||||||||||||||||||||||||||
h-index | 100 | ||||||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||||||
自引率 (2023-2024) | 4.40%自引率趨勢 | ||||||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/drug-resistance-updates/ | ||||||||||||||||||||||||||||||||
在線稿件提交 | |||||||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||||||
出版商 | Churchill Livingstone | ||||||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||||||||||
創刊年 | 1998 | ||||||||||||||||||||||||||||||||
每年文章數 | 72每年文章數趨勢 | ||||||||||||||||||||||||||||||||
黃金OA百分比 | 40.00% | ||||||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1368-7646%5BISSN%5D | ||||||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Invited contributions ? Irregular | ||||||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Difficult | ||||||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[DRUG RESISTANCE UPDATES] 的評論 | 撰寫評論 |
作者: 削月会强 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-14 20:13:00 評論於 Wow, this is taking too much time(0) 讚! | 削月会强 |
作者: john888 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-15 15:05:35 評論於 Is it easy for senior experts to review submissions? Is it difficult to find reviewers?(0) 讚! | john888 |
作者: 中原向雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-13 19:51:48 評論於 How are you doing?(0) 讚! | 中原向雪 |
作者: 中原向雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-13 15:01:31 評論於 Did you not find the reviewer's rejection?(0) 讚! | 中原向雪 |
作者: 中原向雪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-11 13:57:52 評論於 Have you received this piece of drug article?(0) 讚! | 中原向雪 |
作者: 削月以松 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-04 17:04:51 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Research focus: Antimicrobial resistance sharing experience: Previously a review journal so the impact factor is very high (>20) but the reputation is average. Starting to accept articles in 2023 (The overall quality of the articles is decent, but may not reach the top 20 level) The final stability level is still to be observed. There are suitable articles. Why not try submitting one?(0) 讚! | 削月以松 |
作者: Tomorrow's sun 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-01-17 14:38:44 評論於 The latest partition in 2024 is not from a top journal, which is indeed confusing. What's the point of changing it back and forth?(0) 讚! | Tomorrow's sun |
作者: 破戒淑琴 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-11 13:44:03 評論於 How long will it take to meet with the editor later?(0) 讚! | 破戒淑琴 |
作者: 破戒淑琴 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-09 22:58:00 評論於 Submission success rate: 25.0 Research focus: Microbial drug resistance Sharing experience: Hey friends, how long does it take for this journal submission to reach the editor with edits?(0) 讚! | 破戒淑琴 |
作者: 罗汉沈然 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-09-30 15:50:25 評論於 Do you have any feedback on the manuscript?(0) 讚! | 罗汉沈然 |
作者: 景焕小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-11 09:02:33 評論於 2-4 days(0) 讚! | 景焕小姐姐 |
作者: 映真郎 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-10 20:00:32 評論於 Do you have a link?(0) 讚! | 映真郎 |
作者: 金山静梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-10 10:49:03 評論於 In general, parents should listen to their children more, even if what the children are saying is not important(0) 讚! | 金山静梅 |
作者: 金山静梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-08 13:13:25 評論於 Dr. Bik is reporting Chen Zhe Sheng's peer review fraud(0) 讚! | 金山静梅 |
作者: 景焕小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-07 13:10:18 評論於 Review speed: 3.0 | Submission acceptance rate: 25.0 Emphasized research direction: drug resistance Experience sharing: Record the process for reference: After submission, waited more than 20 days for the editor's handling, waited 2 months for external review, and waited 20 days for RRC and other editor's handling, then got rejected. The editor's processing efficiency is low, and it is difficult to find expert reviewers(0) 讚! | 景焕小姐姐 |
作者: 金山静梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-06 14:35:13 評論於 Editor-in-chief Chen Zhesheng is currently being reported by Dr. Bik(0) 讚! | 金山静梅 |
作者: 天池骊颖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-03 11:26:07 評論於 How long after "with editor" will it be sent for external review?(0) 讚! | 天池骊颖 |
作者: 景焕小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-20 17:08:59 評論於 Uncertain, but it usually takes a long time to hear back from the editor, which indicates the risk of having the manuscript rejected at the initial review(0) 讚! | 景焕小姐姐 |
作者: 苍风虹影 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-17 23:08:00 評論於 Does it take so long to submit for external review? Will you wait that long to reject directly, or is it common to submit for external review when it takes a long time?(0) 讚! | 苍风虹影 |
作者: 景焕小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-20 15:46:43 評論於 About 25 days with editor(0) 讚! | 景焕小姐姐 |
作者: 一条小勇毅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-11 09:00:20 評論於 Was there any change later?(0) 讚! | 一条小勇毅 |
作者: 景焕小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-30 12:25:01 評論於 Which brother has submitted an article to this journal? Can you share your experience? How many days after submitting the manuscript can you be with the editor? Currently, it has been 21 days and the status is still manuscript submitted(0) 讚! | 景焕小姐姐 |
作者: 无定玉香 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-22 08:03:59 評論於 Drug resistance related direction(0) 讚! | 无定玉香 |
作者: 坠星倩影 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-07 11:38:18 評論於 Drug Resistance Updates Impact Factor Changes: 2019-2021 The impact factor of the past three years has shown a year-on-year increasing trend, with a JCR 2021 impact factor of 22.841, JCR 2020 impact factor of 18.500, and JCR 2019 impact factor of 11.000, showing a growth of 107.6% in the past two years(0) 讚! | 坠星倩影 |
作者: 坠星倩影 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-06 12:48:33 評論於 Review Speed: 2.0 | Acceptance Rate: 25.0 Experience Sharing: Drug Resistance Updates invited Professor Zhe-Sheng Chen to be the new Editor-in-Chief in July 2022. Professor Chen is an expert in the field of drug resistance and has published over 400 articles. He is also a member of the editorial board of 27 journals and a peer reviewer for over 200 journals. According to data from Web of Science, before Professor Chen took over as Editor-in-Chief, Drug Resistance Updates mainly accepted Review articles. According to the latest news from the editorial office, since the new Editor-in-Chief Professor Chen took office in July 2022, the journal is now accepting full-length research articles for submission! Welcome everyone to submit high-quality articles to Drug Resistance Updates(0) 讚! | 坠星倩影 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us